VIVUS, Inc. Made Headway

Tue 14 Jul 20 at 05:30 PM
VIVUS, Inc. Made Headway

VIVUS, Inc. (VVUS:NASDAQ) rocketted at $0.61, representing a gain of 32.4%. On Mon 13 Jul 20, VVUS:NASDAQ touched a New 2-Week Low of $0.46. The stock appeared on our News Catalysts scanner on Wed 08 Jul 20 at 11:23 AM in the 'BIOTECH' category. From Mon 29 Jun 20, the stock recorded 11.11% Up Days and 20.00% Green Days

The stock spiked on Mon 08 Jun 20 at $1.47 with a volume of 2M+.


VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.